Inventor
MUNDT WOLFGANG
AT64 patents
⚠️ This page may combine multiple inventors who share the name “MUNDT WOLFGANG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
IMMUNO AG
12 patentsUS6100061AAug 8, 2000
Recombinant cell clone having increased stability in serum- and protein-free medium and a method of recovering the stable cell clone and the production of recombinant proteins by using a stable cell clone
IMMUNO AG229 citations99
US5753489AMay 19, 1998
Method for producing viruses and vaccines in serum-free culture
IMMUNO AG133 citations98
US5854403ADec 29, 1998
Method for isolation of highly pure von Willebrand Factor
IMMUNO AG53 citations96
US5100799AMar 31, 1992
Method for releasing cell cultures from microcarriers
IMMUNO AG24 citations93
US4923817AMay 8, 1990
Fermenter for culturing cell cultures
IMMUNO AG29 citations93
US5880265AMar 9, 1999
Method for isolation of highly pure von willebrand factor
IMMUNO AG22 citations92
US5756341AMay 26, 1998
Method for controlling the infectivity of viruses
IMMUNO AG52 citations92
US5550051AAug 27, 1996
Avian embryo cell aggregate biomass for producing virus/virus antigen and method for producing virus/virus antigen
IMMUNO AG19 citations92
US5698433ADec 16, 1997
Method for producing influenza virus and vaccine
IMMUNO AG18 citations84
US5877152AMar 2, 1999
Method for isolation of highly pure von Willebrand Factor
IMMUNO AG14 citations82
US5391491AFeb 21, 1995
Avian embryo cell aggregate biomass for producing tick-born encephalitis virus/virus antigen
IMMUNO AG19 citations81
US5719051AFeb 17, 1998
Perfusion system and a method for the large scale production of virus or virus antigen
IMMUNO AG15 citations74
BAXALTA INC
12 patentsUS9714411B2Jul 25, 2017
Animal protein-free media for cultivation of cells
BAXALTA INC16 citations93
US9409971B2Aug 9, 2016
Method of producing recombinant high molecular weight vWF in cell culture
BAXALTA INC15 citations93
US9809796B2Nov 7, 2017
Animal protein-free media for cultivation of cells
BAXALTA INC13 citations90
US9758568B2Sep 12, 2017
Oligopeptide-free cell culture media
BAXALTA INC10 citations84
US10138461B2Nov 27, 2018
Animal protein-free media for cultivation of cells
BAXALTA INC2 citations73
US9732327B2Aug 15, 2017
Formulation of sugar solutions for continuous ultracentrifugation for virus purification
BAXALTA INC2 citations72
US10822394B2Nov 3, 2020
Method of producing recombinant high molecular weight vWF in cell culture
BAXALTA INC0 citations52
US10655099B2May 19, 2020
Animal protein-free media for cultivation of cells
BAXALTA INC0 citations52
USRE46897EJun 19, 2018
Recombinant cell clones having increased stability and methods of making and using the same
BAXALTA INC0 citations52
US9982286B2May 29, 2018
Medium for the protein-free and serum-free cultivation of cells
BAXALTA INC0 citations52
USRE46860EMay 22, 2018
Recombinant cell clones having increased stability and methods of making and using the same
BAXALTA INC0 citations52
US9834591B2Dec 5, 2017
Method of producing recombinant high molecular weight vWF in cell culture
BAXALTA INC0 citations52
REITER MANFRED
6 patentsUS8524497B2Sep 3, 2013
Animal protein free media for cultivation of cells
REITER MANFRED28 citations91
US8084252B2Dec 27, 2011
Recombinant cell clones having increased stability and methods of making and using the same
REITER MANFRED5 citations74
US8080414B2Dec 20, 2011
Recombinant cell clones having increased stability and methods of making and using the same
REITER MANFRED3 citations74
US8969533B2Mar 3, 2015
Formulation of sugar solutions for continuous ultracentrifugation for virus purification
REITER MANFRED4 citations71
US8722406B2May 13, 2014
Medium for the protein-free and serum-free cultivation of cells
REITER MANFRED1 citations62
US8703467B2Apr 22, 2014
Inactivation of a pathogen in a sample by a treatment with formalin and UV light
REITER MANFRED3 citations62
BAXTER AG
5 patentsUS6936441B2Aug 30, 2005
Recombinant cell clones having increased stability and methods of making and using the same
BAXTER AG160 citations99
US6475725B1Nov 5, 2002
Recombinant cell clones having increased stability and methods of making and using the same
BAXTER AG119 citations99
US6372223B1Apr 16, 2002
Influenza virus vaccine composition
BAXTER AG101 citations98
US7094574B2Aug 22, 2006
Recombinant cell clones having increased stability and methods of making and using the same
BAXTER AG32 citations96
US6103693AAug 15, 2000
Method for isolation of highly pure von willebrand factor
BAXTER AG27 citations92
BAXTER HEALTHCARE SA
3 patentsUS6951752B2Oct 4, 2005
Method for large scale production of virus antigen
BAXTER HEALTHCARE SA55 citations96
US7524676B2Apr 28, 2009
Large scale productions of virus antigen
BAXTER HEALTHCARE SA24 citations93
US6855535B2Feb 15, 2005
Method of large scale production of Hepatitis A virus
BAXTER HEALTHCARE SA9 citations72
GRILLBERGER LEOPOLD
2 patentsBAXTER INNOVATIONS GMBH
2 patentsBAXTER INT
2 patentsTAKEDA PHARMACEUTICALS CO
2 patentsCHEMBIOMED LTD
1 patentKISTNER OTFRIED
1 patentMUNDT WOLFGANG
1 patentBaxalta GmbH
1 patentShowing the top 50 of 64 patents by PatentIndex Score.